Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.81B
Enterprise Value6.92B
P/E Ratio186.84
PEG Ratio-2.54
Price/Sales Ratio7.55
Price/Book Ratio6.46
Enterprise/Revenue7.75
Enterprise/EBITDA176.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue1.22B
Revenue/Share9.64
Gross Profit634.32M
EBITDA277.26M
Net Income203.87M
Diluted EPS1.86

Balance Sheet

Total Cash544.94M
Total Cash/Share4.99
Total Debt682.7M
Total Debt/Equity0.57
Current Ratio1.71
Book Value Per Share11.12

Price History

52-Week Change10.66
52-Week High80.7
52-Week Low46.68
Moving Average 50 Days66.37
Moving Average 200 Days62.76

Statistics

Average Volume3.39M
Shares Outstanding112M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.19
Trailing Annual Dividend Yield0.26
Payout Ratio0.74
Last Split Factor7:5
Last Split DateMay 12, 2023
AD